Kazuya Koizumi Selected Research

Kazuya Koizumi Research Topics

Disease

11	Neoplasms (Cancer) 03/2022 - 09/2009
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 03/2004
5	Stomach Neoplasms (Stomach Cancer) 03/2013 - 01/2009
4	Adenocarcinoma 12/2020 - 08/2010
3	Cysts 03/2022 - 01/2008
3	Hemorrhage 10/2021 - 11/2012
3	Pancreatic Fistula (Pancreatic Fistulas) 12/2015 - 01/2011
2	Cholangitis 05/2022 - 10/2021
2	Neoplasms, Cystic, Mucinous, and Serous 12/2020 - 05/2011
2	Pathologic Constriction (Stenosis) 08/2020 - 06/2015
2	Fistula 02/2020 - 12/2015
2	Pancreatitis 02/2020 - 06/2015
2	Ascites 12/2017 - 03/2017
2	Body Weight (Weight, Body) 12/2017 - 03/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017 - 03/2017
2	Bile Duct Neoplasms (Bile Duct Cancer) 01/2017 - 05/2004
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Cholecystitis 10/2021
1	Proteinuria 01/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2021
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021
1	Carcinoma (Carcinomatosis) 12/2020
1	Infections 08/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 02/2020
1	Necrosis 02/2020
1	Heart Arrest (Cardiac Arrest) 02/2020
1	Hypertension (High Blood Pressure) 01/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Dementia (Dementias) 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Disseminated Intravascular Coagulation 01/2017
1	Shock 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2016
1	Hemangiosarcoma (Angiosarcoma) 08/2016
1	Lymphedema (Milroy Disease) 08/2016
1	Stewart Treves syndrome 08/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2016
1	Pancreaticobiliary Maljunction 01/2016
1	Carcinogenesis 01/2016
1	Liver Abscess 08/2015
1	Disease Progression 08/2015
1	Abscess 08/2015
1	Intestinal Neoplasms (Intestinal Cancer) 06/2014

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 09/2010 - 03/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 08/2015
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 11/2012
2	AnticoagulantsIBA 10/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 10/2017
2	Cell-Free Nucleic AcidsIBA 12/2020 - 10/2017
2	Pharmaceutical PreparationsIBA 12/2017 - 03/2017
2	DiureticsIBA 12/2017 - 03/2017
2	Keratins (Keratin)IBA 08/2016 - 01/2016
2	tachocombIBA 12/2015 - 01/2011
2	MucinsIBA 05/2011 - 09/2009
2	Cisplatin (Platino)FDA LinkGeneric 05/2011 - 02/2011
2	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 03/2011 - 01/2011
2	p38 Mitogen-Activated Protein KinasesIBA 09/2005 - 03/2004
1	BilirubinIBA 03/2022
1	GoldIBA 03/2022
1	lenvatinibIBA 03/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	PlasticsIBA 08/2020
1	Codon (Codons)IBA 06/2020
1	Branched-Chain Amino AcidsIBA 12/2017
1	SodiumIBA 03/2017
1	Tolvaptan FDA Link 03/2017
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 08/2016
1	phytobacteriomycin (PBM)IBA 01/2016
1	Fibrinogen (Factor I)FDA Link 12/2015
1	Thrombin FDA Link 12/2015
1	CollagenIBA 12/2015
1	TachoSilIBA 12/2015
1	Ointments (Pastes)IBA 08/2015
1	Metronidazole (Metric)FDA LinkGeneric 08/2015

Therapy/Procedure

9	Therapeutics 05/2022 - 03/2004
3	Drug Therapy (Chemotherapy) 01/2021 - 09/2010
3	Pancreatectomy 06/2020 - 03/2011
3	Gastrectomy 03/2013 - 01/2009
2	Endoscopic Sphincterotomy 10/2021 - 06/2015
2	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 02/2011
2	Pancreaticoduodenectomy 06/2014 - 01/2011
2	Length of Stay 03/2011 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 10/2009 - 01/2006
1	Radiofrequency Ablation 03/2022
1	Radiotherapy 03/2022
1	Decompression 10/2021
1	Stents 08/2020
1	Punctures 08/2020
1	Metastasectomy 06/2020
1	Cardiopulmonary Resuscitation (CPR) 02/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2020
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 02/2020
1	Laparotomy 01/2017
1	Hepatectomy 01/2017
1	Chemoradiotherapy 08/2016
1	Hysterectomy 08/2016
1	Cholecystectomy 01/2016
1	Self Expandable Metallic Stents 06/2015